Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of DDR signalling kinases (ATM, ATR, CHK1 and CHK2) allows senescent cells to re-enter the cell cycle7,24,25”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“In normal cells, however, oncogenic RAS causes genotoxic stress and senescence [ 57 , 58 ], inducing a SASP and thereby conferring complex cell-nonautonomous oncogenic activities.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [57]
In the citing paper
“Indeed, most oncogenes that have been studied in the literature cause replication stress by increasing origin firing and triggering DNA damage [12, 29]”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [12]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Di Micco et al. 2006
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186
RetractedA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Cited by
Items 901–1,000 of 1,011
c-Myc-induced Aberrant DNA Synthesis and Activation of DNA Damage Response in p300 Knockdown Cells
Natesan, S., Kadeppagari, R., & Thimmapaya, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900776200 · Cited by 33
Meyer, M., Rübsamen, D., Slany, R. K., Illmer, T., Stabla, K., Roth, P., Stiewe, T., Eilers, M., & Neubauer, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007768 · Cited by 32
“Second, oncogenic Ras can induce a DNA damage response in primary cells, which leads to activation of the Atm and Atr checkpoint kinases [24,25,31].”
BackgroundTug of War between Survival and Death: Exploring ATM Function in Cancer
Stagni, V., Oropallo, V., Fianco, G., Antonelli, M., Cinà, I., & Barilà, D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045388 · Cited by 36
“DDR markers in this context correlate with the occurrence of markers of senescence and in vitro and in vivo experiments support the requirement of the DDR for senescence induction in response to replicative stress elicited by oncogenes [39–41].”
BackgroundTsao, W.-C., & Eckert, K. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103255 · Cited by 32
“Moreover, hyper-replication was accompanied by increased origin firing and partly replicated DNA which were reminiscent of aphidicolin-treated cells [159].”
BackgroundHistone chaperone FACT is essential to overcome replication stress in mammalian cells
Prendergast, L. A., Hong, E., Safina, A. F., Poe, D., & Gurova, K. V. (2020) · Oncogene · doi:10.1038/s41388-020-1346-9 · Cited by 32
Iglesias–Ara, A., Zenarruzabeitia, O., Fernández‐Rueda, J., Sànchez‐Tilló, E., Field, S. J., Celada, A., & Zubiaga, A. M. (2010) · Oncogene · doi:10.1038/onc.2010.296 · Cited by 33
Lenglez, S., Hermand, D., & Decottignies, A. (2010) · Genome Research · doi:10.1101/gr.104513.109 · Cited by 35
Understanding the interplay between dNTP metabolism and genome stability in cancer
Yagüe-Capilla, M., & Rudd, S. G. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050775 · Cited by 36
“Replication stress and the induction of DNA damage activates the DNA damage response (DDR; Box 1) (Bartkova et al., 2006; Di Micco et al., 2006), largely controlled by the ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) kinases, which in turn activate the p53…”
Pereira, S. M., Ribeiro, R., & Logarinho, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040938 · Cited by 34
“DNA-damaging stressors activate p53 through DNA damage response (DDR) signaling (ionizing radiation [20,21], chemotherapeutics [22], oncogenic proliferation [23]), leading to the up-regulation of the p53 transcriptional target p21, which, in turn, induces a cell-cycle arrest by inhibiting cyclin E-Cdk2.”
BackgroundBreak‐induced replication plays a prominent role in long‐range repeat‐mediated deletion
Hu, Q., Lu, H., Wang, H., Li, S., Truong, L. N., Li, J., Liu, S., Xiang, R., & Wu, X. (2019) · The EMBO Journal · doi:10.15252/embj.2019101751 · Cited by 35
“Thus, BIR/RMD plays a more significant role than SSA in inducing RMD-associated chromosomal structure changes during oncogenesis, when both oncogenic stress and replication fork collapse are evident (Bartkova et al , 2006; Di Micco et al , 2006).”
Manic, G., Musella, M., Corradi, F., Sistigu, A., Vitale, S., Rehim, S. S. A., Mattiello, L., Malacaria, E., Galassi, C., Signore, M., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00733-4 · Cited by 31
Marullo, R., Rutherford, S. C., Revuelta, M. V., Zamponi, N., Čuljković, B., Kotlov, N., Siervi, N. D., Lara-Garcia, J., Allan, J. N., Ruan, J., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1992 · Cited by 33
“Cancer cells arecontinuouslyexposedtoDNAdamageduetoreplicationstressthat originates in the dysregulated S-phase progression driven by aberrant expression of speci fi c oncogenes, among which is MYC (39, 40).”
BackgroundPML links aberrant cytokine signaling and oncogenic stress to cellular senescence
Bourdeau, V. (2009) · Frontiers in Bioscience · doi:10.2741/3256 · Cited by 30
“In mouse cells and in some human cells, inactivation of one of these pathways is sufficient to prevent senescence in response to oncogenes (11, 12).”
BackgroundBravo, M., Nicolini, F., Starowicz, K., Barroso, S. I., Calés, C., Aguilera, A., & Vidal, M. (2015) · Journal of Cell Science · doi:10.1242/jcs.173021 · Cited by 42
“The approach overcomes functional redundancy and avoids inducing replication stress, which is associated with oncogene expression (Bartkova et al., 2006; Di Micco et al., 2006) when used to immortalise cultures (Piunti et al., 2014).”
BackgroundVijayakumar, S., Dziegielewska, B., Levin, D. S., Song, W., Yin, J., Yang, A. J., Matsumoto, Y., Bermudez, V. P., Hurwitz, J., & Tomkinson, A. E. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01732-08 · Cited by 33
“5B), each of which is indicative of cellular senescence possibly triggered by DNA damage (2, 9).”
BackgroundXPO7 is a tumor suppressor regulating p21CIP1-dependent senescence
Innes, A. J., Sun, B., Wagner, V., Brookes, S., McHugh, D., Pombo, J., Porreca, R. M., Dharmalingam, G., Vernia, S., Zuber, J., et al. (2021) · Genes & Development · doi:10.1101/gad.343269.120 · Cited by 30
Connecting the dots: Neuronal senescence, stress granules, and neurodegeneration
Ma, Y., & Farny, N. G. (2023) · Gene · doi:10.1016/j.gene.2023.147437 · Cited by 33
Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships
Mantovani, F., Zannini, A., Rustighi, A., & Sal, G. D. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.013 · Cited by 37
POU transcription factors in melanocytes and melanoma
Besch, R., & Berking, C. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.10.001 · Cited by 31
Ruan, J., Liao, Y., Lua, I., Li, M.-H., Hsu, C.-Y., & Chen, J. H. (2012) · Breast Cancer Research · doi:10.1186/bcr3226 · Cited by 33
Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis
Mikawa, T., Shibata, E., Shimada, M., Ito, K., Ito, T., Kanda, H., Takubo, K., LLeonart, M. E., Inagaki, N., Yokode, M., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101306 · Cited by 35
Une re-vue de la sénescence cellulaire: Ami ou ennemi de la promotion tumorale ?
Bischof, O., Dejean, A., & Pineau, P. (2009) · médecine/sciences · doi:10.1051/medsci/2009252153 · Cited by 32
Bypassing cellular senescence by genetic screening tools
Vergel, M., & Carnero, A. (2010) · Clinical & Translational Oncology · doi:10.1007/s12094-010-0528-2 · Cited by 32
The Role of p53/p21/p16 in DNA-Damage Signaling and DNA Repair
Kulaberoglu, Y., Gündoğdu, R., & Hergovich, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00015-x · Cited by 51
Thaler, S., Schmidt, M., Schad, A., & Sleeman, J. P. (2012) · Oncogene · doi:10.1038/onc.2011.658 · Cited by 33
Truong, L. N., Li, Y., Sun, E., Ang, K., Hwang, P. Y.-H., & Wu, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576488 · Cited by 30
“Importantly, certain oncogenes, such as H-RasV12 and CycD1-P287A disrupt the licensing control and induce DNA rereplication (60, 61).”
BackgroundReplication stress, a source of epigenetic aberrations in cancer?
Jasencakova, Z., & Groth, A. (2010) · BioEssays · doi:10.1002/bies.201000055 · Cited by 31
Dillenburg, C. S., Martins, M. A. T., Almeida, L. O., Meurer, L., SQUARIZE, C. H., Martins, M. D., & CASTILHO, R. M. (2015) · Medicine · doi:10.1097/md.0000000000000997 · Cited by 30
Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy
Jo, U., & Kim, H. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0175 · Cited by 33
“…induced by oncogene activation triggers DDR as a natural barrier to prevent malignancy; thus, inactivation of DDR promotes cellular transformation, and mutations in DDR factors are frequently found in various human cancers (Bartkova et al., 2006; Di Micco et al., 2006; Kandoth et al., 2013).”
BackgroundColosio, A., Frattini, C., Pellicanò, G., Villa‐Hernández, S., & Bermejo, R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw858 · Cited by 31
Critical DNA damaging pathways in tumorigenesis
Kloeber, J. A., & Lou, Z. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.012 · Cited by 30
Revelations About Aging and Disease from Unconventional Vertebrate Model Organisms
Zhao, Y., Seluanov, A., & Gorbunova, V. A. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-021009 · Cited by 32
“There are multiple types of cellular senescence, including replicative senescence (RS) (69; 106) induced by telomere shortening, oncogene-induced senescence (OIS) (16; 39; 155), and stress-induced premature senescence (SIPS) (180; 181) triggered by DNA damage.”
BackgroundLi, B., Zhang, G. C., Wang, Z., Yang, Y., Wang, C., Fang, D., Liu, K., Wang, F., & Mei, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04330-2 · Cited by 30
Aberrant R-loop-induced replication stress in MED12-mutant uterine fibroids
Muralimanoharan, S., Shamby, R., Stansbury, N. M., Schenken, R. S., Avalos, B. D. L. P., Javanmardi, S., Dray, E. V., Sung, P., & Boyer, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-10188-x · Cited by 29
Wajapeyee, N., Wang, S.-Z., Serra, R. W., Solomon, P. D., Nagarajan, A. G., Zhu, X., & Green, M. R. (2010) · Blood · doi:10.1182/blood-2009-09-245928 · Cited by 29
Revised genetic requirements for the decatenation G2 checkpoint: The role of ATM
Bower, J. J., Zhou, Y., Zhou, T., Simpson, D. A., Arlander, S. J. H., Paules, R. S., Cordeiro‐Stone, M., & Kaufmann, W. K. (2010) · Cell Cycle · doi:10.4161/cc.9.8.11470 · Cited by 31
“Cell cycle checkpoint responses are associated with oncogeneinduced senescence, supporting a hypothesis that checkpoints are barriers to the development of cancer.(1,2) Since cell cycle checkpoints slow growth and stabilize the genome, defects in these checkpoints are thought to enhance clonal growth and genomic insta…”
BackgroundAnimal models in the study of hepatitis C virus-associated liver pathologies
Lerat, H., Higgs, M. R., & Pawlotsky, J. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.14 · Cited by 29
Major heat shock protein Hsp72 controls oncogene‐induced senescence
Sherman, M. Y. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05196.x · Cited by 33
Antagonistic TSC22D1 variants control BRAFE600‐induced senescence
Cornelia, H.-H., van Doorn, R., Vogel, C., Germann, M., Cecchini, M. G., Verdegaal, E. M. E., & Peeper, D. S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.95 · Cited by 31
“The DNA damage response (DDR) has been suggested to contribute to senescence as well (Bartkova et al, 2006; Di Micco et al, 2006; Mallette et al, 2007).”
Background“Breaking Up Is Hard to Do”: The Formation and Resolution of Sister Chromatid Intertwines
Baxter, J. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.08.022 · Cited by 29
“phase, and this also causes replicative stress [105-107] and potentially increases in SCI.”
BackgroundArmeni, T., Ercolani, L., Urbanelli, L., Magini, A., Magherini, F., Pugnaloni, A., Piva, F., Modesti, A., Emiliani, C., & Principato, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052151 · Cited by 28
“Previous studies showed that oncogenic H-Ras induces proliferative arrest or senescence by activating S-phase-specific DNA-damage checkpoint response (DDR) followed by apoptotic cell death [10] or that the expression of oncogenic H-Ras leads to caspase-independent cell death with autophagy features [4].”
BackgroundThe Intricate Interplay between Mechanisms Underlying Aging and Cancer
Piano, A., & Titorenko, V. I. (2014) · Aging and Disease · doi:10.14336/ad.2014.0209 · Cited by 31
“Noteworthy, some genetic manipulations and senescence triggers in culture can cause a senescenceassociated irreversible S, G2 or G2/M cell cycle arrest [12, 101, 181-183].”
BackgroundDNA replication stress drives fragile site instability
Sinai, M. I., & Kerem, B. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.10.002 · Cited by 28
Yangonin inhibits ethanol-induced hepatocyte senescence via miR-194/FXR axis
Dong, R., Wang, X., Wang, L., Wang, C., Huang, K., Fu, T., Liu, K., Wu, J., Sun, H., & Meng, Q. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173653 · Cited by 30
The tumor suppression theory of aging
Wolf, A. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111583 · Cited by 30
SIRT6 Through the Brain Evolution, Development, and Aging
García-Venzor, A., & Toiber, D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.747989 · Cited by 29
“NBS is also an autosomal recessive disease commonly accompanied by microcephaly and developmental retardation (Digweed and Sperling, 2004).”
BackgroundCáceres-Gutiérrez, R. E., Alfaro‐Mora, Y., Andonegui, M. A., Díaz‐Chávez, J., & Herrera, L. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.751367 · Cited by 28
Cell Senescence and Central Regulators of Immune Response
Lunin, S. M., Novoselova, E. G., Glushkova, O. V., Parfenyuk, S. B., Novoselova, T. V., & Khrenov, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084109 · Cited by 31
“The primary mechanisms underlying this dependence and determining the fate of the cell are a network of signalling pathways including the PI3KAKT-mTOR, Ras-MEK-ERK, p53-p21-Rb, and p16-Rb pathways.”
BackgroundInfluentialLee, Y. S., Ahmed, M. B., Alghamdi, A. A. A., Islam, S. U., & Ahsan, H. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220826141837 · Cited by 31
Cyclin‐dependent kinases as therapeutic targets in melanoma
Miller, D. M., & Flaherty, K. T. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12211 · Cited by 32
“Persistent mitogenic stimulation promotes replicative stress leading to DNA damage, activation of the DNA damage response, and irreversible cell-cycle arrest (Di Micco et al., 2006).”
BackgroundRSK4 inhibition results in bypass of stress-induced and oncogene-induced senescence
López-Vicente, L., Pons, B., Coch, L., Teixidó, C., Hernández‐Losa, J., Armengol, G., & y Cajal, S. R. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr003 · Cited by 32
Induction of p38δ Expression Plays an Essential Role in Oncogenic ras-Induced Senescence
Kwong, J., Chen, M. S., Lv, D., Luo, N., Su, W., Xiang, R., & Sun, P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00784-13 · Cited by 29
“mutant human p53 (1-61) were prepared as described previously (27).”
BackgroundMethodInfluentialDNA Ligase 1 is an essential mediator of sister chromatid telomere fusions in G2 cell cycle phase
Liddiard, K., Ruis, B. L., Kan, Y., Cleal, K., Ashelford, K. E., Hendrickson, E. A., & Baird, D. M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1279 · Cited by 30
Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer
Zhou, J., Zhang, Y., Zou, X., Kuai, L., Wang, L., Wang, J., Shen, F., Hu, J., Zhang, X., Huang, Y., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.080 · Cited by 28
“30 Timeless is a member of replication fork complex that confers to fork stabilization and prevents the collapse of the stalled replication fork.”
Senescence and Cancer: Role of Nitric Oxide (NO) in SASP
Mabrouk, N., Ghione, S., Laurens, V., Plenchette, S., Bettaïeb, A., & Paul, C. (2020) · Cancers · doi:10.3390/cancers12051145 · Cited by 31
“hyperproliferation, aberrant replication and activation of the DDR [12,13].”
BackgroundInfluentialA Link between Replicative Stress, Lamin Proteins, and Inflammation
Willaume, S., Rass, E., Fontanilla-Ramirez, P., Moussa, A., Wanschoor, P., & Bertrand, P. (2021) · Genes · doi:10.3390/genes12040552 · Cited by 30
miR‐20a and miR‐290, multi‐faceted players with a role in tumourigenesis and senescence
Rizzo, M., Mariani, L., Pitto, L., Rainaldi, G., & Simili, M. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01173.x · Cited by 28
“Oncogene activation, which induces DNA damage due to DNA hyper-replication [6], is a strong inducer of extrinsic senescence in both MEF and HF: in this case senescence represents a potent anti-tumourigenic mechanism protecting the organism from unwanted cell proliferation.”
BackgroundLife-span Extension Drug Interventions Affect Adipose Tissue Inflammation in Aging
Mau, T., O’Brien, M., Ghosh, A. K., Miller, R. A., & Yung, R. L. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz177 · Cited by 30
Erber, J., Steiner, J. D., Isensee, J., Lobbes, L. A., Toschka, A., Beleggia, F., Schmitt, A., Kaiser, R. W. J., Siedek, F., Persigehl, T., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3959 · Cited by 33
Genomic instability and cancer: lessons from Drosophila
Gerlach, S. U., & Herranz, H. (2020) · Open Biology · doi:10.1098/rsob.200060 · Cited by 29
Chitwood, D. G., Wang, Q., Elliott, K. S., Bullock, A., Jordana, D., Li, Z., Wu, C. H., Harcum, S. W., & Saski, C. A. (2021) · BMC Biotechnology · doi:10.1186/s12896-020-00667-2 · Cited by 30
Pond, K. W., Morris, J. M., Alkhimenok, O., Varghese, R. P., Cabel, C. R., Ellis, N. A., Chakrabarti, J. L., Zavros, Y. L., Merchant, J. L., Thorne, C. A., et al. (2022) · eLife · doi:10.7554/elife.78837 · Cited by 34
Ota, S., Zhou, Z.-Q., Link, J. M., & Hurlin, P. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp195 · Cited by 30
“While senescence appears to be triggered by multiple mechanisms, recent evidence indicates that senescence induced by mutant Ras and several other oncogenic proteins is associated with the development of DNA strand breaks that may arise due to defects in DNA replication (32,33).”
BackgroundIdentification of genes that are essential to restrict genome duplication to once per cell division
Vassilev, A. P., Lee, C. Y., Vassilev, B., Zhu, W., Ormanoglu, P., Martin, S. E., & Depamphilis, M. (2016) · Oncotarget · doi:10.18632/oncotarget.9008 · Cited by 29
“Normal cells respond to DNA damage by arresting cell proliferation until the damage is repaired [25], whereas a robust DNA damage response in cancer cells elicits apoptosis [26, 27].”
BackgroundMoudrá, A., Hubáčková, S., Machalová, V., Vančurová, M., Bártek, J., Reiniš, M., Hodný, Z., & Jonasova, A. T. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1183860 · Cited by 28
“MDS low risk group number of patients 94 number of samples 125 number of patients with multiple BM aspirations 31 patient age at BM aspiration (years), median (range) 72 (46-86) males/females 54 / 71”
BackgroundChakraborty, S., Rasool, R. U., Kumar, S., Nayak, D., Rah, B., Katoch, A., Amin, H., Ali, A., & Goswami, A. (2016) · AGE · doi:10.1007/s11357-016-9922-1 · Cited by 31
Glucocorticoids delay RAF-induced senescence promoted by EGR1
Carvalho, C., L’Hôte, V., Courbeyrette, R., Kratassiouk, G., Pinna, G., Cintrat, J., Wilkes, C. D., Derbois, C., Olaso, R., Deleuze, J., et al. (2019) · Journal of Cell Science · doi:10.1242/jcs.230748 · Cited by 29
Passananti, C., Floridi, A., & Fanciulli, M. (2007) · Biochemistry and Cell Biology · doi:10.1139/o07-062 · Cited by 30
Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy
Hamerlik, P., Darling, J. L., & Bartek, J. J. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00153.x · Cited by 28
Gene Therapy for Advanced Melanoma: Selective Targeting and Therapeutic Nucleic Acids
Viola, J. R., Rafael, D. F. D. S., Wagner, E., Besch, R., & Ogris, M. (2013) · Journal of Drug Delivery · doi:10.1155/2013/897348 · Cited by 29
Giorgio, E. D., Dalla, E., Tolotto, V., D’Este, F., Paluvai, H., Ranzino, L., & Brancolini, C. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae501 · Cited by 29
Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy
Yang, H., Liu, D., Qiu, L., Wang, R., Zhang, C., Yu, D., Zhong, Q., Yuki, N., Song, Z., Zhu, Τ., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02459-8 · Cited by 38
“…transcriptional silencing of cell-proliferation genes, activation of tumor suppressor pathways (e.g., p53), and formation of repressive heterochromatin [30–32]. thereby acting as a critical intrinsic tumor suppressor mechanism that prevents outgrowth of cells with aberrant mitogenic signaling.”
Repression of cancer cell senescence by PKCι
Paget, J., Restall, I. J., Daneshmand, M., Mersereau, J. A., Simard, M. A., Parolin, D. A. E., Lavictoire, S. J., Amin, M. S., Islam, S., & Lorimer, I. A. J. (2011) · Oncogene · doi:10.1038/onc.2011.524 · Cited by 27
Never-ageing cellular senescence
Öğrünç, M., & di Fagagna, F. D. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.003 · Cited by 37
Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner
Etxebeste-Mitxeltorena, M., del Rincón-Loza, I., & Martín-Antonio, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717850 · Cited by 28
ZNF768 links oncogenic RAS to cellular senescence
Villot, R., Poirier, A., Bakan, I., Boulay, K., Fernández, E., Devillers, R., Braga, L. G., Tribouillard, L., Gagné, A., Duchesne, É., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24932-w · Cited by 31
“His-p53 Δ-CTD was subcloned in MSCV using pGEX-human p53 (1-320) as a template (gift from Cheryl Arrowsmith, Addgene plasmids #24864).”
MethodInactivation of the Hippo tumor suppressor pathway promotes melanoma
Vittoria, M. A., Kingston, N. M., Kotýnková, K., Xia, E., Hong, R., Huang, L., McDonald, S., Tilston-Lünel, A., Darp, R., Campbell, J. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31399-w · Cited by 31
“Supporting this view, it has been demonstrated that expression of BRAFV600E in primary melanocytes in vitro induces an immediate cell cycle arrest and that these arrested melanocytes exhibit all of the hallmarks of oncogene-induced senescence: they become large, flat, vacuolar, express p16INK4A, display senescence-ass…”
BackgroundTargeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care
Thompson, E. L., Pitcher, L. E., Niedernhofer, L. J., & Robbins, P. D. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009668 · Cited by 29
Mechanisms of Senescence and Anti-Senescence Strategies in the Skin
Konstantinou, E. K., Longange, E., & Kaya, G. (2024) · Biology · doi:10.3390/biology13090647 · Cited by 35
DGCR8-mediated disruption of miRNA biogenesis induces cellular senescence in primary fibroblasts
Gómez-Cabello, D., Adrados, I., Gamarra, D., Kobayashi, H., Takatsu, Y., Takatsu, K., Gil, J., & Palmero, I. (2013) · Aging Cell · doi:10.1111/acel.12117 · Cited by 28
“As an alternative explanation for the senescent phenotype, we also investigated if suppression of DGCR8 could lead to DNA damage, a potential trigger of senescence (Di Micco et al., 2006).”
BackgroundThe Myc/macrophage tango: Oncogene-induced senescence, Myc style
Lee, S., Schmitt, C. A., & Reimann, M. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.002 · Cited by 32
Chayot, R., Danckaert, A., Montagne, B., & Ricchetti, M. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.09.001 · Cited by 31
Drug-induced premature senescence model in human dental follicle stem cells
Zhai, Y., Wei, R., Liu, J., Wang, H., Cai, W., Zhao, M., Hu, Y., Wang, S., Yang, T., Liu, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14085 · Cited by 26
“For instance, oncogenic Ras serves by overexpression of Cell Division Cycle 6 and suppression of nucleotide metabolism, leading to double stranded DNA breaks, aberrant DNA replication, and activation of the DNA damage repair signaling pathway [29, 30].”
BackgroundA Lamin-Binding Ligand Inhibits Homologous Recombination Repair of DNA Double-Strand Breaks
Li, B. X., Chen, J., Chao, B., Zheng, Y., & Xiao, X. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00379 · Cited by 28
Replication stress: Driver and therapeutic target in genomically instable cancers
Schoonen, P. M., Llobet, S. G., & van Vugt, M. A. T. M. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.10.006 · Cited by 27
Nesprin-1 impact on tumorigenic cell phenotypes
Sur‐Erdem, İ., Hussain, M. S., Asif, M., Degirmenci, N. P., Aksu, A. C., & Noegel, A. A. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05184-w · Cited by 26
The inflammatory network: bridging senescent stroma and epithelial tumorigenesis
Shan, W., Yang, G. S., & Liu, J. (2009) · Frontiers in bioscience · doi:10.2741/3511 · Cited by 34
“These studies suggest that RAS activation may lead to a strong hyperproliferative phase followed by a senescence response possibly due to activation of the DNA damage response following hyper-replication of DNA, mediated by ataxia telangiectasia mutated (ATM), CHK kinase I (CHK1), and CHK kinase II (CHK2) signaling pa…”
BackgroundThe Role of the Transcriptional Response to DNA Replication Stress
Herlihy, A. E., & de Bruin, R. A. M. (2017) · Genes · doi:10.3390/genes8030092 · Cited by 29
“Oncogene-induced replication stress is thought to induce DNA damage, with the DNA damage response (reviewed in [30,31]) acting as an initial barrier to tumourigenesis through oncogene-induced senescence or apoptosis [25,32,33].”
BackgroundBid Plays a Role in the DNA Damage Response
Zinkel, S. S., Hurov, K. E., & Gross, A. (2007) · Cell · doi:10.1016/j.cell.2007.06.035 · Cited by 26
Asbestos: Modern Insights for Toxicology in the Era of Engineered Nanomaterials
Felley-Bosco, E., & MacFarlane, M. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00146 · Cited by 23
DNA damage response in proliferating Müller glia in the mammalian retina
Nomura-Komoike, K., Saitoh, F., Komoike, Y., & Fujieda, H. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-18101 · Cited by 25
Targeting vascular senescence in cardiovascular disease with aging
Hall, S. A., & Lesniewski, L. A. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.45 · Cited by 32
“FOXOs are tumor suppressors that contribute to the regulation of many functions including cell growth and survival, metabolism, and oxidative stress by regulating the expression of several target genes [28,29] .”
BackgroundAt a Crossroads: Human DNA Tumor Viruses and the Host DNA Damage Response
Nikitin, P. A., & Luftig, M. A. (2011) · Future Virology · doi:10.2217/fvl.11.55 · Cited by 27
“The DNA damage response acts as an innate barrier to tumorigenesis In recent years, the DNA damage response (DDR) has become recognized as an important innate tumor suppressor pathway [1,2].”
BackgroundInfluentialDNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia
Krishnan, V., Lim, D. X. E., Hoang, P. M., Srivastava, S., Matsuo, J., Huang, K. K., Zhu, F., Ho, K. Y., So, J. B. Y., Khor, C. J. L., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319002 · Cited by 26
Non‐canonical ATM/MRN activities temporally define the senescence secretory program
Malaquin, N., Carrier-Leclerc, A., Martinez, A., Dessureault, M., Ghadaouia, S., Coppé, J., Nadeau, S., Cardin, G., Campisi, J., & Rodier, F. (2020) · EMBO Reports · doi:10.15252/embr.202050718 · Cited by 30
“…of genotoxic stresses (i.e., telomere shortening, oncogene-induced mitotic stress, irradiation) that cause DNA double-strand breaks (DSBs) and a DNA damage response (DDR) signaling cascade (d’Adda di Fagagna et al , 2003; Bartkova et al , 2005; Di Micco et al , 2006; Mallette et al , 2007).”
Mesenchymal Stem Cell Senescence and Osteogenesis
Tjempakasari, A., Suroto, H., & Santoso, D. (2021) · Medicina · doi:10.3390/medicina58010061 · Cited by 29
“In addition, this type of senescence may also strongly induce DDR due to DNA damage caused by abnormal DNA replication [50,51] and ROS [5,39–43].”
BackgroundQian, J., Zhou, X., Tanaka, K., & Takahashi, A. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103572 · Cited by 27
Gauthier, M. G., Herrick, J., & Bechhoefer, J. (2010) · Physical Review Letters · doi:10.1103/physrevlett.104.218104 · Cited by 27
Novel ARF/p53-independent senescence pathways in cancer repression
Chan, C., Gao, Y., Moten, A., & Lin, H. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0766-y · Cited by 29
“Moreover, the DDR is found to be induced in cells with Ras-induced senescence, and inactivation of the DDR abolishes OIS and promotes cellular transformation in vitro [60, 61].”
BackgroundOkudaira, N., Goto, M., Yanobu‐Takanashi, R., Tamura, M., An, A., Abe, Y., Kano, S., Hagiwara, S., Ishizaka, Y., & Okamura, T. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02060.x · Cited by 26
Metadata
- Authors
- Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., Maestro, R., Giuseppe Pelicci, P., & d’Adda di Fagagna, F.
- Affiliations
- IFOM (IT)
- European Institute of Oncology (IT)
- Centro di Riferimento Oncologico (IT)
- Institut Pasteur (FR)
- Genomic Vision (France) (FR)
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2121371748
- Cited by
- 1,821
- References
- 30
- Citations by year
- 2026: 50 · 2025: 58 · 2024: 62 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 84 · 2019: 81 · 2018: 104 · 2017: 84 · 2016: 110 · 2015: 89 · 2014: 118 · 2013: 107 · 2012: 115
- FWCI
- 58.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, DNA damage response, H-Ras V12, origin of replication, DNA replication fork progression, cell transformation, carcinogenesis, senescence markers, DNA combing
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Cells, Cultured, DNA Replication, Genetic Markers, Humans, Genes, ras, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.